Glenmark Pharmaceuticals Market Cap

Glenmark Pharmaceuticals has a market cap or net worth of 425.88 billion as of April 1, 2025. Its market cap has increased by 59.68% in one year.

Market Cap

425.88B

Enterprise Value

425.48B

Revenue

139.61B

Ranking

n/a

PE Ratio

n/a

Stock Price

1,540.05

Market Cap Chart

Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 425.88B, an increase of 36,955.35%. That is a compound annual growth rate of 28.17%.

Market Cap History

Date	Market Cap	% Change
Apr 1, 2025	425.88B	-6.21%
Dec 31, 2024	454.07B	88.44%
Dec 29, 2023	240.96B	101.33%
Dec 30, 2022	119.68B	-19.75%
Dec 31, 2021	149.14B	7.10%
Dec 31, 2020	139.25B	42.03%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Reliance Industries	15.92T
HDFC Bank	13.53T
Tata Consultancy Services	12.85T
Bharti Airtel	10.33T
ICICI Bank	9,317.41B
State Bank of India	6,887.13B
Infosys	6,323.60B
Bajaj Finance	5,383.23B

Market Cap Rankings